29 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
oversight responsibilities, the Audit Committee reviewed and discussed with management Aligos’ audited financial statements as of and for the year … Oversight Board (the “PCAOB”). In addition, the Audit Committee has received the written disclosures and the letter from EY required by PCAOB Ethics
8-K
EX-10.1
ALGS
Aligos Therapeutics Inc
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
Oversight Board (United States) and as required by the Securities Act.
(p) With respect to the stock options (the “Stock Options”) granted pursuant
S-3
EX-1.2
dpu8eqrm3raq
4 Nov 21
Shelf registration
4:57pm
424B4
ped7dk
1 Jul 21
Prospectus supplement with pricing info
4:31pm
DRS
mgpdfl78
4 Jun 21
Draft registration statement
12:00am